About all

Can hpv cause yeast infections. Association between Common Vaginal and HPV Infections and Cytology Test Results in Shanghai, China (2014-2019)

by alexxlab

Can HPV cause yeast infections? Explore the association between vaginal and HPV infections and cytology test results in the Zhoupu District of Shanghai, China from 2014 to 2019.

Содержание

Examining the Relationship Between Vaginal and HPV Infections in Shanghai

Researchers conducted a comprehensive study to investigate the association between common vaginal infections and human papillomavirus (HPV) infections, as well as their impact on cytology test results in the Zhoupu District of Shanghai, China, from 2014 to 2019. This study aimed to provide valuable insights into the intricate interactions between these prevalent health conditions and their implications for cervical cancer screening and prevention.

Global Burden of Cervical Cancer and the Role of HPV

Cervical cancer remains a significant global health concern, with an estimated 604,127 new cases and 341,831 deaths worldwide in 2020, according to the GLOBOCAN study. The study also highlighted the disproportionate burden of cervical cancer in low- and middle-income countries, where access to effective screening and prevention measures is often limited.

The causal link between HPV infection and cervical cancer is well-established. HPV is responsible for nearly all cases of cervical cancer, with certain high-risk HPV genotypes playing a crucial role in the development of this disease. Understanding the epidemiology and distribution of HPV infections is crucial for implementing effective prevention strategies, such as vaccination and screening programs.

Prevalence of Cervical HPV Infection in Shanghai

Previous studies have examined the prevalence of cervical HPV infection in the Zhoupu District of Shanghai, China. These studies have reported relatively high rates of HPV infection, particularly among younger women, underscoring the need for comprehensive screening and prevention measures in this population.

The Role of Vaginal Microbiome and Infections in Cervical Cancer

Emerging evidence suggests that the vaginal microbiome and common vaginal infections may play a crucial role in the development and progression of cervical cancer. Certain vaginal microbiome compositions and the presence of specific vaginal pathogens, such as Trichomonas vaginalis, have been associated with an increased risk of cervical intraepithelial neoplasia and cervical cancer.

Investigating the Association Between Vaginal Infections and Cytology Test Results

The current study aimed to explore the relationship between common vaginal infections, including bacterial vaginosis, candidiasis, and trichomoniasis, and their association with the results of cytology tests among women in the Zhoupu District of Shanghai. Cytology testing, also known as the Pap test, is a widely used screening method for the early detection of cervical cancer and precancerous lesions.

Methodology and Data Collection

The study was conducted in the Zhoupu District of Shanghai, China, from 2014 to 2019. Data was collected from routine gynecological examinations, including cytology tests and diagnoses of common vaginal infections. The researchers analyzed the association between the presence of vaginal infections and the results of cytology tests, using appropriate statistical methods to identify any significant relationships.

Findings and Implications

The study findings provide valuable insights into the complex interplay between vaginal infections and HPV infections, and their potential impact on cervical cancer screening. The results can inform the development of comprehensive preventive strategies, including improved screening protocols and targeted interventions to address the underlying factors that contribute to the burden of cervical cancer in the Zhoupu District and similar communities.

By understanding the nuanced relationships between these health conditions, healthcare providers and policymakers can implement more effective measures to reduce the incidence and mortality of cervical cancer, ultimately improving the overall well-being of the population.

Association between common vaginal and HPV infections and results of cytology test in the Zhoupu District, Shanghai City, China, from 2014 to 2019

1. Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71:209–249. doi: 10.3322/caac.21660. [PubMed] [CrossRef] [Google Scholar]

2. Bonjour M, Charvat H, Franco EL, Piñeros M, Clifford GM, Bray F, Baussano I. Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis. The Lancet Public Health. 2021;6(7):e510–e521. doi: 10.1016/S2468-2667(21)00046-3. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

3. Chen T, Wei M, Liu Y, Wang H, Zhou W, Bi Y, Zhang Z. Rising mortality rate of cervical cancer in younger women in urban China. J Gen Intern Med. 2020;35:593. doi: 10.1007/s11606-019-05174-5. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

4. Iarc WG. Human papillomaviruses: IARC monographs on the evaluation of carcinogenic risks to humans. ARC Monogr Eval Carcinog Risks Hum. 2007;90:1–636. [PMC free article] [PubMed] [Google Scholar]

5. Valdez M, Jeronimo J, Bansil P, Qiao Y, Zhao F, Chen W, Zhang X, Kang L, Paul P, Bai P, Peck R, Li J, Chen F, Stoler M, Castle P. Effectiveness of novel, lower cost molecular human papillomavirus-based tests for cervical cancer screening in rural china. Int J Cancer. 2016;138:1453–1461. doi: 10.1002/ijc.29877. [PubMed] [CrossRef] [Google Scholar]

6. Li H, Li P, Huang L, Sun L, Ren H, Li P. Prevalence characteristics of cervical human papillomavirus (HPV) infection in the Zhoupu District, Shanghai City, China. Virol J. 2020;17:84. doi: 10.1186/s12985-020-01352-8. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

7. Campos N, Burger E, Sy S, Sharma M, Schiffman M, Rodriguez A, Hildesheim A, Herrero R, Kim J. An updated natural history model of cervical cancer: derivation of model parameters. Am J Epidemiol. 2014;180:545–555. doi: 10.1093/aje/kwu159. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

8. Senapati R, Nayak B, Kar S, Dwibedi B. HPV Genotypes distribution in Indian women with and without cervical carcinoma: Implication for HPV vaccination program in Odisha, Eastern India. BMC Infect Dis. 2017;17:30. doi: 10.1186/s12879-016-2136-4. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

9. Singh V, Sehgal A, Satyanarayana L, Gupta M, Parashari A, Chattopadhya D. Clinical presentation of gynecologic infections among Indian women. Obstet Gynecol. 1995;85:215–219. doi: 10.1016/0029-7844(94)00367-M. [PubMed] [CrossRef] [Google Scholar]

10. Campisciano G, Gheit T, De Seta F, Cason C, Zanotta N, Delbue S, Ricci G, Ferrante P, Tommasino M, Comar M. Oncogenic virome benefits from the different vaginal microbiome-immune axes. Microorganisms. 2019;7(10):414. doi: 10. 3390/microorganisms7100414. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

11. Kovachev S. Cervical cancer and vaginal microbiota changes. Arch Microbiol. 2020;202:323–327. doi: 10.1007/s00203-019-01747-4. [PubMed] [CrossRef] [Google Scholar]

12. Brotman R, Shardell M, Gajer P, Tracy J, Zenilman J, Ravel J, Gravitt P. Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection. J Infect Dis. 2014;210:1723–1733. doi: 10.1093/infdis/jiu330. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

13. Clarke M, Rodriguez A, Gage J, Herrero R, Hildesheim A, Wacholder S, Burk R, Schiffman M. A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection. BMC Infect Dis. 2012;12:33. doi: 10.1186/1471-2334-12-33. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

14. Chase D, Goulder A, Zenhausern F, Monk B, Herbst-Kralovetz M. The vaginal and gastrointestinal microbiomes in gynecologic cancers: a review of applications in etiology, symptoms and treatment. Gynecol Oncol. 2015;138:190–200. doi: 10.1016/j.ygyno.2015.04.036. [PubMed] [CrossRef] [Google Scholar]

15. Gram I, Macaluso M, Churchill J, Stalsberg H. Trichomonas vaginalis (TV) and human papillomavirus (HPV) infection and the incidence of cervical intraepithelial neoplasia (CIN) grade III. Cancer Causes Control CCC. 1992;3:231–236. doi: 10.1007/BF00124256. [PubMed] [CrossRef] [Google Scholar]

16. Socioeconomic differences in rates of cesarean section. The New England journal of medicine. 1990. 322:268–70. [PubMed]

17. Winer R, Hughes J, Feng Q, Xi L, Cherne S, O’Reilly S, Kiviat N, Koutsky L. Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women. Cancer Epidemiol Biomark Prev. 2011;20:699–707. doi: 10.1158/1055-9965.EPI-10-1108. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

18. de Sanjosé S, Brotons M, Pavón M. The natural history of human papillomavirus infection. Best Pract Res Clin Obstet Gynaecol. 2018;47:2–13. doi: 10.1016/j.bpobgyn.2017.08.015. [PubMed] [CrossRef] [Google Scholar]

19. Kiseki H, Tsukahara Y, Tajima N, Tanaka A, Horimoto A, Hashimura N. Influence of co-infection complicated with human papillomavirus on cervical intraepithelial neoplasia development in patients with atypical squamous cells of undetermined significance. J Infect Chemother Off J Jpn Soc Chemother. 2017;23:814–819. doi: 10.1016/j.jiac.2017.08.008. [PubMed] [CrossRef] [Google Scholar]

20. Teng P, Hao M. A population-based study of age-related associations between vaginal pH and the development of cervical intraepithelial neoplasia. Cancer Med. 2020;9:1890–1902. doi: 10.1002/cam4.2845. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

21. Tindle R. Immune evasion in human papillomavirus-associated cervical cancer. Nat Rev Cancer. 2002;2:59–65. doi: 10.1038/nrc700. [PubMed] [CrossRef] [Google Scholar]

22. Smith J, Herrero R, Bosetti C, Muñoz N, Bosch F, Eluf-Neto J, Castellsagué X, Meijer C, Van den Brule A, Franceschi S, Ashley R. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst. 2002;94:1604–1613. doi: 10.1093/jnci/94.21.1604. [PubMed] [CrossRef] [Google Scholar]

23. Gupta M, Sharma B, Singh V, Luthra U. Immunocytological demonstration of HSV-II antigen on exfoliated cells from precancerous and cancerous lesions of the uterine cervix. Diagn Cytopathol. 1988;4:48–49. doi: 10.1002/dc.2840040112. [PubMed] [CrossRef] [Google Scholar]

24. Misra J, Srivastava S, Singh U, Srivastava A. Risk-factors and strategies for control of carcinoma cervix in India: hospital based cytological screening experience of 35 years. Indian J Cancer. 2009;46:155–159. doi: 10.4103/0019-509X.49155. [PubMed] [CrossRef] [Google Scholar]

25. Pandit A, Khili P, Powar H, Bhave G, Chadda N. Detection of HSV-2 antigen in carcinoma cervix and premalignant conditions by immuno-cytochemistry. J Postgrad Med. 1990;36:185–190. [PubMed] [Google Scholar]

26. Koffa M, Koumantakis E, Ergazaki M, Tsatsanis C, Spandidos D. Association of herpesvirus infection with the development of genital cancer. Int J Cancer. 1995;63:58–62. doi: 10.1002/ijc.2910630112. [PubMed] [CrossRef] [Google Scholar]

27. Galloway D, McDougall J. The oncogenic potential of herpes simplex viruses: evidence for a ‘hit-and-run’ mechanism. Nature. 1983;302:21–24. doi: 10.1038/302021a0. [PubMed] [CrossRef] [Google Scholar]

28. Kulomaa P, Paavonen J, Lehtinen M. Herpes simplex virus induces unscheduled DNA synthesis in virus-infected cervical cancer cell lines. Res Virol. 1992;143:351–359. doi: 10.1016/S0923-2516(06)80123-8. [PubMed] [CrossRef] [Google Scholar]

29. Dhanwada KR, Garrett L, Smith P, Thompson KD, Doster A, Jones C. Characterization of human keratinocytes transformed by high risk human papillomavirus types 16 or 18 and herpes simplex virus type 2. J Gen Virol. 1993;74(6):955–963. doi: 10.1099/0022-1317-74-6-955. [PubMed] [CrossRef] [Google Scholar]

30. Muñoz N, Kato I, Bosch F, De Sanjosé S, Sundquist V, Izarzugaza I, Gonzalez L, Tafur L, Gili M, Viladiu P. Cervical cancer and herpes simplex virus type 2: case-control studies in Spain and Colombia, with special reference to immunoglobulin-G sub-classes. Int J Cancer. 1995;60:438–442. doi: 10.1002/ijc.2910600403. [PubMed] [CrossRef] [Google Scholar]

31. Lehtinen M, Koskela P, Jellum E, Bloigu A, Anttila T, Hallmans G, Luukkaala T, Thoresen S, Youngman L, Dillner J, Hakama M. Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries. Am J Epidemiol. 2002;156:687–692. doi: 10.1093/aje/kwf098. [PubMed] [CrossRef] [Google Scholar]

32. Wang W, Zhang X, Li M, Hao C, Liang H. Association between vaginal infections and the types and viral loads of human papillomavirus: a clinical study based on 4449 cases of gynecologic outpatients. Can J Infect Dis Med Microbiol J canadien des maladies infectieuses et de la microbiologie medicale. 2020;2020:9172908. [PMC free article] [PubMed] [Google Scholar]

33. Kharsany A, Hoosen A, Moodley J, Bagaratee J, Gouws E. The association between sexually transmitted pathogens and cervical intra-epithelial neoplasia in a developing community. Genitourin Med. 1993;69:357–360. [PMC free article] [PubMed] [Google Scholar]

34. Frega A, Lavini G, Guarino A, Giovanale V, Lukic A, Bianchi P, Cozza G, Marziani R, D’Ambrosio A, French D, Caserta D. Cervical carcinogenesis, bacterial vaginosis, HPV-mRNA test and relapse of CIN2+ after loop electrosurgical excision procedure (LEEP) Eur Rev Med Pharmacol Sci. 2017;21:2504–2511. [PubMed] [Google Scholar]

35. Coudray M, Madhiva P. Bacterial vaginosis-A brief synopsis of the literature. Eur J Obstet Gynecol Reprod Biol. 2020;245:143–148. doi: 10.1016/j.ejogrb.2019.12.035. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

36. Usyk M, Zolnik C, Castle P, Porras C, Herrero R, Gradissimo A, Gonzalez P, Safaeian M, Schiffman M, Burk R. Cervicovaginal microbiome and natural history of HPV in a longitudinal study. PLoS Pathog. 2020;16:e1008376. doi: 10.1371/journal.ppat.1008376. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

37. Murphy K, Mitchell CM. The interplay of host immunity, environment and the risk of bacterial vaginosis and associated reproductive health outcomes. J Infect Dis. 2016;214(suppl 1):S29–S35. doi: 10.1093/infdis/jiw140. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

38. Yang M, Li L, Jiang C, Qin X, Zhou M, Mao X, Xing H. Co-infection with trichomonas vaginalis increases the risk of cervical intraepithelial neoplasia grade 2–3 among HPV16 positive female: a large population-based study. BMC Infect Dis. 2020;20:642. doi: 10.1186/s12879-020-05349-0. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

39. da Costa R, de Souza W, Benchimol M, Alderete J, Morgado-Diaz J. Trichomonas vaginalis perturbs the junctional complex in epithelial cells. Cell Res. 2005;15:704–716. doi: 10.1038/sj.cr.7290340. [PubMed] [CrossRef] [Google Scholar]

40. Fichorova R, Lee Y, Yamamoto H, Takagi Y, Hayes G, Goodman R, Chepa-Lotrea X, Buck O, Murray R, Kula T, Beach D, Singh B, Nibert M. Endobiont viruses sensed by the human host – beyond conventional antiparasitic therapy. PLoS ONE. 2012;7:e48418. doi: 10.1371/journal.pone.0048418. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

41. Lazenby G, Taylor P, Badman B, McHaki E, Korte J, Soper D, Young Pierce J. An association between Trichomonas vaginalis and high-risk human papillomavirus in rural Tanzanian women undergoing cervical cancer screening. Clin Ther. 2014;36:38–45. doi: 10.1016/j.clinthera.2013.11.009. [PubMed] [CrossRef] [Google Scholar]

42. Ganguly S, Mitchell A. Mucosal biofilms of Candida albicans. Curr Opin Microbiol. 2011;14:380–385. doi: 10.1016/j.mib.2011.06.001. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

43. Ghosh I, Muwonge R, Mittal S, Banerjee D, Kundu P, Mandal R, Biswas J, Basu P. Association between high risk human papillomavirus infection and co-infection with Candida spp. and Trichomonas vaginalis in women with cervical premalignant and malignant lesions. J Clin Virol Off Pub Pan Am Soc Clin Virol. 2017;87:43–48. doi: 10.1016/j.jcv.2016.12.007. [PubMed] [CrossRef] [Google Scholar]

44. Shang-Ying H, Tsang SH, Chen F, Pan Q-J, Zhang W-H, Hong Y, Sampson JN, Hildesheim A, Zhao F-H, Kreimer AR. Association between common vaginal infections and cervical non–human papillomavirus (HPV) 16/18 infection in HPV-vaccinated women. J Infect Dis. 2020;223(3):445–451. doi: 10.1093/infdis/jiaa384. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

45. Mason P, Super H, Fripp P. Comparison of four techniques for the routine diagnosis of Trichomonas vaginalis infection. J Clin Pathol. 1976;29:154–157. doi: 10.1136/jcp.29.2.154. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

46. Puran A, Adler D, Wallace M, Bennie T, Phuti A, Abar B, Bekker L. Incidental findings of bacterial vaginosis and other infections in papanicolaou smears of HIV-infected and HIV-uninfected adolescent females in South Africa. J AIDS HIV Res. 2014;6:172–176. [PMC free article] [PubMed] [Google Scholar]

47. Kanyina EW, Kamau L, Muturi M. Cervical precancerous changes and selected cervical microbial infections, Kiambu County, Kenya, 2014: a cross sectional study. BMC Infect Dis. 2017;17:647. doi: 10.1186/s12879-017-2747-4. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

48. Workowski KA. Centers for disease control and prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis. 2015;61(suppl 8):S759–S762. doi: 10.1093/cid/civ771. [PubMed] [CrossRef] [Google Scholar]

49. Amsel R, Totten P, Spiegel C, Chen K, Eschenbach D, Holmes K. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983;74:14–22. doi: 10.1016/0002-9343(83)91112-9. [PubMed] [CrossRef] [Google Scholar]

50. Schwebke J, Gaydos C, Nyirjesy P, Paradis S, Kodsi S, Cooper C. Diagnostic performance of a molecular test versus clinician assessment of vaginitis. J Clin Microbiol. 2018;56:e00252. [PMC free article] [PubMed] [Google Scholar]

51. Schwiertz A, Taras D, Rusch K, Rusch V. Throwing the dice for the diagnosis of vaginal complaints? Ann Clin Microbiol Antimicrob. 2006;5:4. doi: 10.1186/1476-0711-5-4. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

52. Brotman R. Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. J Clin Investig. 2011;121:4610–4617. doi: 10.1172/JCI57172. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

53. Briselden A, Hillier S. Evaluation of affirm VP microbial identification test for gardnerella vaginalis and trichomonas vaginalis. J Clin Microbiol. 1994;32:148–152. doi: 10.1128/jcm.32.1.148-152.1994. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

54. Cartwright C, Lembke B, Ramachandran K, Body B, Nye M, Rivers C, Schwebke J. Comparison of nucleic acid amplification assays with BD affirm VPIII for diagnosis of vaginitis in symptomatic women. J Clin Microbiol. 2013;51:3694–3699. doi: 10.1128/JCM.01537-13. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

55. Gaydos C, Beqaj S, Schwebke J, Lebed J, Smith B, Davis T, Fife K, Nyirjesy P, Spurrell T, Furgerson D, Coleman J, Paradis S, Cooper C. Clinical validation of a test for the diagnosis of vaginitis. Obstet Gynecol. 2017;130:181–189. doi: 10.1097/AOG.0000000000002090. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

56. Schwebke J, Hobbs M, Taylor S, Sena A, Catania M, Weinbaum B, Johnson A, Getman D, Gaydos C. Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial. J Clin Microbiol. 2011;49:4106–4111. doi: 10.1128/JCM.01291-11. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

57. Schwebke JR, Hillier SL, Sobel JD, McGregor JA, Sweet RL. Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol. 1996;88:573–576. doi: 10.1016/0029-7844(96)00233-5. [PubMed] [CrossRef] [Google Scholar]

Abnormal pap smears and yeast infections: Is there a link?

A yeast infection can impact the results of a Pap smear. The presence of a yeast infection can cause some cells to appear abnormal. However, these cells are not related to cancer.

Yeast infections occur when the amount of Candida albicans, a type of yeast in the vagina, grows out of control. Symptoms usually include itching, burning, and inflammation around the vagina and vulva. A person may also develop a whitish coating around the vagina.

This article examines how yeast infections can affect the results of a Pap smear test.

It also discusses what to do if a person has a yeast infection before their Pap smear appointment and other factors that can cause abnormal results.

A Pap smear samples cells from the cervix to look for any changes caused by human papillomavirus (HPV) that can lead to cervical cancer if left untreated.

According to the National Cancer Institute (NCI), yeast infections can lead to an abnormal Pap smear finding called atypical squamous cells of undetermined significance (ASC-US).

ASC-US is the most common abnormal Pap smear result. It means that some of the cells do not appear normal and it is not clear if HPV is the cause.

Do yeast infections cause abnormal cells?

A yeast infection does not cause abnormal cells. However, it can cause some cells to appear abnormal.

It is important to note that the abnormal appearance of these cells is not related to cancer.

If a person has symptoms of a yeast infection, or is taking medications for a yeast infection, they should inform the doctor before the Pap smear appointment.

The doctor may suggest that they rearrange the Pap smear until a person has finished treating the yeast infection.

In some cases, a yeast infection may not cause any symptoms, so a person may not know they have it. In this case, the Pap smear result may come back as ASC-US.

If this happens, the NCI states that the doctor may perform an HPV test if they did not do this previously to determine if the abnormal result is due to HPV.

Learn more about treating a yeast infection here.

Vaginitis refers to the inflammation of the vagina that can occur due to a disruption of the vaginal microbiome. A yeast infection is a type of vaginitis.

According to an older 2011 study, the risk of developing vaginitis may rise slightly in the 7 weeks following a Pap smear test.

This may happen due to the use of lubricant and the speculum, which could alter the balance of vaginal organisms. However, more research is necessary to establish a definite risk.

The NCI states that the following can cause abnormal Pap smear results:

  • vaginal irritation
  • growths, such as polyps in the uterus
  • hormonal changes that occur during menopause or pregnancy

The Centers for Disease Control and Prevention (CDC) recommend avoiding the following before a Pap smear:

  • douching
  • using a tampon
  • sexual activity
  • birth control jelly, foam, or cream
  • medications in the vagina

Pap smear results may return one of several results:

  • Normal: There is no sign of cancer, pre-cancer, or other abnormalities.
  • Unsatisfactory Pap test results: There may not have been enough of a sample, or there may have been blood or mucus hiding the cells. A healthcare professional will request a second screening within 2–4 months.
  • Abnormal: There are changes to the cervical cells. It is important to note that this does not mean a person has cancer. Abnormal results include:
    • ASC-US
    • atypical glandular cells (AGC), which means that there were some abnormal glandular cells
    • low-grade squamous intraepithelial lesions (LSIL), which usually means that HPV has caused low-grade changes
    • high-grade squamous intraepithelial lesions (HSIL), which means that moderately or severely abnormal cervical cells were present
    • atypical squamous cells, cannot exclude HSIL (ASC-H), which means that abnormal cells were present that could be HSIL
    • adenocarcinoma in situ (AIS), which means there is an advanced area of abnormal growth on the cervix
    • cervical cancer cells

Learn more about Pap smears and when to have one here.

A yeast infection can cause some cells to appear abnormal, which means that the results of a Pap smear come back as ASC-US. However, this is not an indication of cervical cancer.

There may also be a slight increased risk of a person developing a yeast infection following a Pap smear due to the introduction of the speculum and lubricant to the vaginal microbiome.

If a person has a yeast infection when they are due a Pap smear, they should contact the doctor to discuss rearranging the appointment.

causes, symptoms and treatments

Content

  • 1 Human papillomavirus: causes, symptoms and treatments
    • 1.1 Human papillomavirus: what is it?
    • 1.2 How is human papillomavirus formed?
    • 1.3 How is human papillomavirus transmitted?
    • 1.4 Human papillomavirus types
    • 1.5 Symptoms caused by human papillomavirus
    • 1.6 Diagnosis of human papillomavirus
    • 1.7 Treatment of human papillomavirus
      • 1. 7.1 Medical treatment
      • 1.7.2 Surgical treatment
    • 1.8 Possible complications of human papillomavirus
    • 1.9 Prevention of human papillomavirus

      • 900 05 1.10 How is human papillomavirus detected?

    • 1.11 Human papillomavirus prognosis
    • 1.12 Q&A:
        • 1.12.0.1 How can one protect against human papillomavirus?
        • 1.12.0.2 Is it possible to get rid of the human papillomavirus completely?
        • 1.12.0.3 What are the symptoms of HPV infection?
        • 1.12.0.4 How is the human papillomavirus vaccination performed?
        • 1.12.0.5 What is the most effective treatment for the HPV virus?
        • 1.12.0.6 What is the chance of developing cervical cancer with HPV?
    • 1.13 Related video:

In this article we will tell you what the human papillomavirus is, what it is, how infection occurs, what symptoms occur and how to treat this disease. Learn all about papillomavirus and how to fight it with us.

Human papillomavirus (HPV) is a virus that is transmitted through sexual contact and can cause various types of cancer. HPV is the most common viral disease associated with cancers of the larynx, uterus, vagina, anus, and penis.

Among the different types of HPV, some types can cause warts on the skin and mucous membranes, including genital warts. Some types of HPV may be harmless and cause little or no harm to human health. However, other types can lead to the development of cancer, and therefore it is important to see a doctor when symptoms appear.

In this article, we look at the causes of HPV, symptoms associated with HPV, and treatments for this infection.

Human papillomavirus: what is it?

Human papillomavirus (HPV) is a tiny virus that infects human skin and mucous membranes. HPV is transmitted through contact with skin or mucous membranes that are infected with the virus, as well as through contact with objects that have come into contact with contaminated skin or mucous membranes.

There are over 200 different types of HPV. Some of these types can cause skin warts, while others have been directly linked to cancers of the cervix, anal canal, larynx, and other organs.

Most people become infected with HPV during their lifetime, but in most cases the virus does not cause any pathological changes or disease. However, some types of HPV can cause thrush and genital warts, which may require treatment.

How is human papillomavirus formed?

Human papillomavirus (HPV) is a group of viruses that are often transmitted through sexual contact and can cause various types of cancer. HPV is found in the skin and is transmitted through skin-to-skin contact, usually through cuts or scrapes.

HPV is a DNA virus that can integrate into the genome of host cells. When this happens, the virus has the ability to change cell division processes and cause a large number of mutations, which can lead to the development of cancer. There are over 100 types of HPV, and most of them cause no noticeable symptoms.

The human immune system can successfully fight HPV and get rid of it within months or years. However, some types of HPV can get stuck in the body and lead to long-term infections and cancer.

  • Human papillomavirus is transmitted through sexual contact.
  • HPV is a DNA virus that can integrate into the genome of host cells and cause mutations.
  • Most of the more than 100 types of HPV cause no noticeable symptoms.

Yes

100%

How is HPV transmitted?

Human papillomavirus is transmitted from one organism to another through contact with infected cells of the skin and mucous membranes. It can be transmitted sexually, but it can also be spread through direct skin or mucosal contact, such as hugging or shaking hands.

It is also possible for the virus to be transmitted from mother to child during pregnancy or while passing through the birth canal. It should be noted that the transmission of the virus does not always lead to the development of pathology in both the child and the mother.

It is important to note that HPV can stay in the body for years without showing up, and can be transmitted when a person’s immune system is weakened or compromised. Prevention of human papillomavirus transmission largely depends on preventive measures such as the use of condoms and avoidance of direct skin and mucous membrane contact with infected areas.

Human papillomavirus types

There are more than 100 types of human papillomavirus (HPV). Each type has its own unique genetic code and can lead to various diseases.

Some types of HPV can cause common warts on the hands and feet, while others can be associated with cancer. The best known are HPV 6 and 11, which cause warts in the genital area and anus.

Other types, such as HPV 16 and 18, are the most dangerous because they can lead to cancer of the cervix, vulva, anus, and throat.

Some types of HPV can also cause moles and warts on the skin, but are not associated with cancer.

HPV vaccines are available to protect against the most dangerous types of the virus. Regular screening testing will help to detect the disease at an early stage and prevent the development of cancer.

Human papillomavirus symptoms

Human papillomavirus can cause different symptoms depending on the type of virus and the site of infection. Some types of the virus can cause warts to form on the skin of the hands, feet, and other parts of the body. These warts can be rough, pointed, or flat and are often itchy and painful.

Human papillomavirus types 16 and 18 can cause cancer of the cervix, penis, vagina, and anus in men and women. Usually there are no symptoms in the first stages of cancer development, but bleeding and pain in the affected area subsequently appear.

The virus can also lead to papillomas in the mouth and throat, which can cause itching, pain when swallowing, voice changes and other symptoms. In women, infection with the virus can lead to a change in the color and smell of vaginal discharge, as well as bleeding after intercourse.

Human papillomavirus diagnosis

Human papillomavirus is a common sexually transmitted infection. In most cases, the virus does not show symptoms, but in some cases it can lead to the development of cervical cancer or other malignant tumors. Therefore, it is important to regularly undergo diagnostics in order to detect the presence of the virus in a timely manner and begin treatment.

Human papillomavirus diagnostics includes:

  1. Genital examination and patient history to determine if there are symptoms of infection;
  2. PCR test to detect viral load on the body;
  3. Colposcopy to assess the condition of the cervix and detect changes in its tissues.

The diagnosis of human papillomavirus is the first step towards a cure. Stay healthy and do not forget the prevention and control of your body.

Human papillomavirus treatment

Conservative treatment

Vegetative warts that appear on the hands and feet can be removed with cryotherapy. This is a procedure in which liquid nitrogen is applied to the surface of the wart, which freezes and destroys the infected tissue.

Other types of papilloma and wart are treated with creams and ointments that contain substances that kill the virus. Immunostimulants are often prescribed to help a weakened body fight infection.

Surgical treatment

With a large number of warts and condylomas, we can use destructive methods of removal. This can be electrocautery, laser removal, excretory urethrotomy, etc.

Surgical treatment is also used to remove papillomas that are located on the mucous membranes (genitals, anus, oral cavity). These can be radical surgeries such as electrosurgery, radio wave surgery, or surgery using a laser.

Human papillomavirus treatment is usually carried out in combination with vaccination, detoxification, immunity stimulation and proper nutrition.

Possible complications of human papillomavirus

Human papillomavirus can cause various complications, especially in the presence of high-risk types of the virus.

  • Development of cancer of the cervix, anus, genital organs in women and men;
  • Appearance of genital warts, polyps and condylomas;
  • Risk of transmission of infection through sexual contact, especially in people with frequent changes of sexual partners;
  • Possibility of transmission of the virus to the newborn during childbirth, which can lead to various health problems;
  • In the case of a weakened immune system, such as with HIV infection or the use of immunosuppressive therapy, the virus can lead to the development of various tumors.

To minimize the risk of complications and related consequences, it is important to have regular preventive examinations, monitor your health and seek medical help if necessary.

Prevention of human papillomavirus

Vaccination is one of the main methods of preventing HPV. There are three types of vaccines designed to prevent this infection. They protect against the most common types of virus. The drugs should be administered in accordance with the manufacturer’s instructions and according to the scheme established by the doctor.

Personal hygiene is also an important aspect. It is necessary to use individual hygiene items, if possible, avoid contact with potential sources of infection, in particular with HPV patients. Regularly check with a gynecologist (women) or a urologist (men), which will help to determine the presence of changes in the body in a timely manner and take measures to eliminate them.

  • Do not abuse alcohol and nicotine. Smoking and alcohol adversely affect the functioning of the immune system, reducing its protective functions.
  • Maintain a healthy lifestyle. Exercise regularly, keep a healthy diet, avoid overwork and stressful situations.
  • Practice safe sex. Use condoms to help reduce the risk of transmission of infections, including HPV.

Proper prevention of HPV infection is an important step in maintaining health and preventing possible complications.

How is human papillomavirus detected?

Human papillomavirus can be detected using various methods and tests. One of them is PCR diagnostics. This method is based on the detection of viral DNA in the cells of a human tissue sample. The patient is swabbed from the vagina, cervix, anus, or other areas where HPV infections can develop.

Another option is colposcopy. This is a method in which a doctor using a special device – a colposcope – examines diseased areas on the cervix. If the doctor detects suspicious changes, then he takes an impression of the vagina, which is sent for histological analysis. Doctors can also conduct a cytological analysis for the presence of altered cells.

It is important to note that women are screened for HPV when they have a pelvic exam. This analysis allows you to detect the presence of the virus and protect yourself from its consequences.

Human papillomavirus prognosis

Human papillomavirus can lead to a variety of diseases, including cancer of the cervix, rectum, and genitals. However, not every infected person develops these diseases.

The risk of developing cancer is related to the type of virus. It is high when infected with HPV 16 and HPV 18 viruses, which cause approximately 70% of cases of cervical cancer. However, a severe course of the disease is possible in rare cases.

In most cases, HPV resolves on its own without causing serious illness. Vaccination and preventive measures can reduce the risk of infection and complications. It is important to visit a doctor to identify problems at the very beginning.

Q&A:

How can you protect yourself from the human papillomavirus?

Vaccination is the main method of preventing HPV. It is also recommended to observe hygiene measures, use condoms, do not use common utensils and personal belongings of patients, lead a healthy lifestyle, do not abuse alcohol and tobacco, and strengthen immunity.

Is it possible to get rid of the human papillomavirus completely?

No, there is no cure for the HPV virus, but treatment can eliminate its manifestations, such as warts and papillomas, and prevent the development of cancer of the cervix and other organs.

What are the symptoms of HPV infection?

One of the most common symptoms is warts on the skin and mucous membranes. Papillomas in intimate places, itching and burning in the genital area, abnormal discharge in women, pain during intercourse are also possible. Often HPV can occur without obvious symptoms.

How is the human papillomavirus vaccination done?

Vaccination against the HPV virus is carried out in several stages. The first dose of the vaccine is given first, followed by two more as scheduled over several months. The range of vaccines against the HPV virus is quite wide, but they are all effective in combating the main strains of the virus. Do not forget that vaccination is not a 100% guarantee of protection against the virus.

What is the most effective treatment for the HPV virus?

Treatment of the HPV virus depends on its symptoms. Warts and papillomas are removed using laser therapy, liquid nitrogen, electrocoagulation or surgery. If cervical dysplasia is identified, treatment may include surgery and the use of chemotherapy and radiation therapy. Strengthening the immune system also plays an important role.

What is the chance of developing cervical cancer with HPV?

The HPV virus is one of the most common causes of cervical cancer. Moreover, the higher the woman’s age, the higher the likelihood of developing cancer when infected with a virus. However, cancerous degeneration of cervical cells does not always occur. To prevent it, it is important to regularly undergo preventive examinations by a gynecologist and treat the identified changes in time.

Related videos:

Treatment of candidiasis (thrush), bacterial vaginosis, human papillomavirus in Naro-Fominsk

Treatment of candidiasis (thrush), bacterial vaginosis, human papillomavirus

Candidiasis or unfortunate thrush in women is a lesion of the vaginal mucosa by a yeast-like fungus of the genus Candida – microorganisms of conditionally pathogenic microflora. This means that fungi constantly live in a woman’s body in a certain amount.
However, under the influence of third-party factors, their concentration increases – the development of the pathological process starts.

It is possible to diagnose and treat thrush and other pathologies of the vaginal mucosa quickly and effectively at the GlavVrach Medical Center in Naro-Fominsk. We care about every customer! Our patients come to us sick and leave healthy! Contact the GlavVrach employee right now, do not hesitate!

Medical treatment of candidiasis in women

As part of therapy, systemic preparations are used, the active components of which penetrate into the bloodstream and act on the provocateur of pathology. Among the representatives: Fluconazole, Flucostat.

In addition to the mentioned medicines, local remedies are involved in the treatment of thrush. They are not only detrimental to the pathogen, but are also able to restore the affected mucous membrane. Among these medicines: Natamycin, Pimafucin. Approximately the same mechanism of action differs in suppositories and vaginal tablets (Terzhinan, Polygynax).

Thrush and bacterial vaginosis are not the same thing

Bacterial vaginosis, like candidiasis, is a lesion of the vaginal mucosa, however, the causative agent in this case is a bacterium (Klebsiela, Bacteroid, Fusobacterium, etc.).

Accordingly, the treatment of bacterial vaginosis will be different. The role of the active component of most of the drugs used is metronidazole (Metrogil, Trichopolum, etc.).

Human papillomavirus treatment

Pathology develops in a woman’s body in response to the weakening of the patient’s immune system. Accordingly, the main task of HPV treatment is to influence the patient’s immunity while eliminating the manifestations of the disease.

The therapeutic course begins with vaccination. It is followed by taking antiviral and immunomodulatory drugs. Since bacterial infections often join the clinical picture with HPV, the patient is prescribed antibiotics. In the case of the formation of genital warts on the mucous membrane, local treatment is indicated (vaginal tablets, suppositories).

Prices for services

Doctors

Galiakbarova Svetlana Vladimirovna

  • Doctor of the highest category
  • Obstetrician-gynecologist
  • Experience since 1997

Read more

Strukova Anna Yurievna

  • Gynecologist
  • Experience since 2008

Read more

Tsislitskaya Elena Vladimirovna

  • Doctor of the highest category
  • Obstetrician-gynecologist
  • Experience since 1991

Read more

Chumak Ekaterina Grigorievna

  • Obstetrician-gynecologist
  • Experience since 2014

Read more

Polozova Olga Mikhailovna

  • Doctor of the first category
  • Gynecologist.